These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 17188604

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
    Richmond EJ, Rogol AD.
    Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
    Clark RG.
    Horm Res; 2004 Dec; 62 Suppl 1():93-100. PubMed ID: 15761240
    [Abstract] [Full Text] [Related]

  • 4. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model.
    Wang W, Iresjö BM, Karlsson L, Svanberg E.
    Clin Nutr; 2000 Apr; 19(2):127-32. PubMed ID: 10867731
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Patient selection for IGF-I therapy.
    Clayton PE, Ayoola O, Whatmore AJ.
    Horm Res; 2006 Apr; 65 Suppl 1():28-34. PubMed ID: 16508331
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diagnostic and therapeutic advances in growth hormone insensitivity.
    David A, Metherell LA, Clark AJ, Camacho-Hübner C, Savage MO.
    Endocrinol Metab Clin North Am; 2005 Sep; 34(3):581-95, viii. PubMed ID: 16085161
    [Abstract] [Full Text] [Related]

  • 12. The role of recombinant insulin-like growth factor I in the treatment of the short child.
    Rosenbloom AL.
    Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance.
    Regan FM, Williams RM, McDonald A, Umpleby AM, Acerini CL, O'Rahilly S, Hovorka R, Semple RK, Dunger DB.
    J Clin Endocrinol Metab; 2010 May; 95(5):2113-22. PubMed ID: 20233784
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of mecasermin rinfabate.
    Kemp SF, Fowlkes JL, Thrailkill KM.
    Expert Opin Biol Ther; 2006 May; 6(5):533-8. PubMed ID: 16610982
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.